MOLLI NEILSON: Open Payments
NPI 1700305265 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,314 in 44 payments from 10 companies in 2025. Trend: 2023 $680 · 2024 $5,272 · 2025 $3,314
Speaker / faculty: $2,150Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 7 | $2,221 |
| GlaxoSmithKline, LLC. | 12 | $288 |
| Phathom Pharmaceuticals, Inc. | 3 | $183 |
| Regeneron Healthcare Solutions, Inc. | 8 | $182 |
| Stryker Corporation | 2 | $178 |
| GENZYME CORPORATION | 6 | $126 |
| Baxter Healthcare | 1 | $49 |
| Amgen Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: Xhance, NUCALA, DUPIXENT, VOQUEZNA, SCOPIS ENT, PERCLOT, TAVNEOS, XPRESS LOPROFILE.
Industry payments across UT — which companies pay providers there.
